Benzyl Bromide

Benzyl Bromide

SCHEMBL7350277

BrCc1ccccc1.CCCc1nn(Cc2ccccc2)c(C(=O)OCc2ccccc2)c1[N+](=O)[O-]

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.45
KMT2A Q03164 3/20 0.45
SMN1; SMN2 Q16637 3/20 0.41
PTGDR2 Q9Y5Y4 2/20 0.39
RECQL P46063 1/20 0.38
COMT P21964 1/20 0.37
TDP1 Q9NUW8 3/20 0.36
MAPK1 P28482 2/20 0.36
SLC6A2 P23975 1/20 0.36
SLC6A3 Q01959 1/20 0.36
LMNA P02545 1/20 0.36
HTT P42858 1/20 0.36
AGTR1 P30556 1/20 0.36
AGTR2 P50052 1/20 0.36
POLB P06746 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
CNR1 P21554 1/20 0.36
ACHE P22303 1/20 0.36
CNR2 P34972 1/20 0.36
CYP3A4 P08684 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6339999 0.95 ALDH1A1 (0.49) ALDH1A1KMT2ASMN1; SMN2PTGDR2RECQL
SCHEMBL6403255 0.82 SMN1; SMN2 (0.50) ALDH1A1KMT2ASMN1; SMN2PTGDR2MAPK1
SCHEMBL6338203 0.80 SMN1; SMN2 (0.60) ALDH1A1KMT2ASMN1; SMN2PTGDR2MAPK1
SCHEMBL14124978 0.75 MAPK1 (0.57) ALDH1A1KMT2ASMN1; SMN2TDP1MAPK1
SCHEMBL9912563 0.71 MAPK1 (0.47) ALDH1A1KMT2ASMN1; SMN2TDP1MAPK1
SCHEMBL6995149 0.70 SMN1; SMN2 (0.52) ALDH1A1KMT2ASMN1; SMN2LMNAHTT
SCHEMBL6995156 0.67 SMN1; SMN2 (0.51) ALDH1A1KMT2ASMN1; SMN2LMNAHTT
SCHEMBL8205572 0.66 SMN1; SMN2 (0.69) ALDH1A1KMT2ASMN1; SMN2MAPK1LMNA
SCHEMBL7000260 0.66 SMN1; SMN2 (0.52) ALDH1A1KMT2ASMN1; SMN2MAPK1LMNA
SCHEMBL6338207 0.65 ALDH1A1 (0.44) ALDH1A1KMT2ASMN1; SMN2PTGDR2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0977756-A1 PYRAZOLOPYRIMIDINONES WHICH INHIBIT TYPE 5 CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE PHOSPHODIESTERASE (cGMP PDE5) FOR THE TREATMENT OF SEXUAL DYSFUNCTION Pfizer Limited (GB) 2000-02-09 EP disclosed
WO-1998049166-A1 PYRAZOLOPYRIMIDINONES WHICH INHIBIT TYPE 5 CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE PHOSPHODIESTERASE (cGMP PDE5) FOR THE TREATMENT OF SEXUAL DYSFUNCTION PFIZER LIMITED (GB) 1998-11-05 WO disclosed